MOTIEJUNAITE, J., E. AKIYAMA, A. COHEN-SOLAL, A. P. MAGGIONI, C. MUELLER, D. J. CHOI, A. KAVOLIUNIENE, J. CELUTKIENE, Jiří PAŘENICA, J. LASSUS, K. KAJIMOTO, N. SATO, O. MIRO, W. F. PEACOCK, Y. MATSUE, A. A. VOORS, C. S. P. LAM, J. A. EZEKOWITZ, A. AHMED, G. C. FONAROW, E. GAYAT, V. REGITZ-ZAGROSEK a A. MEBAZAA. The association of lorg-term outcome and biological sex in patients with acute heart failure from different geographic regions. European heart journal. Oxford: Oxford University Press, 2020, roč. 41, č. 13, s. 1357-1364. ISSN 0195-668X. Dostupné z: https://dx.doi.org/10.1093/eurheartj/ehaa071.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The association of lorg-term outcome and biological sex in patients with acute heart failure from different geographic regions
Autoři MOTIEJUNAITE, J. (440 Litva), E. AKIYAMA (392 Japonsko), A. COHEN-SOLAL (250 Francie), A. P. MAGGIONI (380 Itálie), C. MUELLER (756 Švýcarsko), D. J. CHOI (178 Konžská republika), A. KAVOLIUNIENE (440 Litva), J. CELUTKIENE (440 Litva), Jiří PAŘENICA (203 Česká republika, domácí), J. LASSUS (246 Finsko), K. KAJIMOTO (392 Japonsko), N. SATO (392 Japonsko), O. MIRO (724 Španělsko), W. F. PEACOCK (840 Spojené státy), Y. MATSUE (392 Japonsko), A. A. VOORS (528 Nizozemské království), C. S. P. LAM (702 Singapur), J. A. EZEKOWITZ (124 Kanada), A. AHMED (840 Spojené státy), G. C. FONAROW (840 Spojené státy), E. GAYAT (250 Francie), V. REGITZ-ZAGROSEK (276 Německo) a A. MEBAZAA (250 Francie, garant).
Vydání European heart journal, Oxford, Oxford University Press, 2020, 0195-668X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 29.983
Kód RIV RIV/00216224:14110/20:00116018
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1093/eurheartj/ehaa071
UT WoS 000522664500012
Klíčová slova anglicky Acute heart failure; Gender; Biological sex; Mortality; Prognosis
Štítky 14110211, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 12. 5. 2021 13:15.
Anotace
Aims Recent data from national registries suggest that acute heart failure (AHF) outcomes might vary in men and women, however, it is not known whether this observation is universal. The aim of this study was to evaluate the association of biological sex and 1-year all-cause mortality in patients with AHF in various regions of the world. Methods and Results We analysed several AHF cohorts including GREAT registry (22 523 patients, mostly from Europe and Asia) and OPTIMIZE-HF (26 376 patients from the USA). Clinical characteristics and medication use at discharge were collected. Hazard ratios (HRs) for 1-year mortality according to biological sex were calculated using a Cox proportional hazards regression model with adjustment for baseline characteristics (e.g. age, comorbidities, clinical and laboratory parameters at admission, Left ventricular ejection fraction). In the GREAT registry, women had a Lower risk of death in the year following AHF [HR 0.86 (0.79-0.94), P< 0.001 after adjustment]. This was mostly driven by northeast Asia [n=9135, HR 0.76 (0.67-0.87), P< 0.001], while no significant differences were seen in other countries. In the OPTIMIZE-HF registry, women also had a tower risk of 1-year death [HR 0.93 (0.89-0.97), P < 0.001]. In the GREAT registry, women were less often prescribed with a combination of angiotensin-converting enzyme inhibitors and beta-Mockers at discharge (50% vs. 57%, P = 0.001). Conclusion Globally women with AHF have a lower 1-year mortality and less evidenced-based treatment than men. Differences among countries need further investigation. Our findings merit consideration when designing future global clinical trials in AHF.
VytisknoutZobrazeno: 15. 5. 2024 09:22